Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tetanus toxoid and congenital abnormalities.

A E Czeizel1, M Rockenbauer

  • 1Department of Human Genetics and Teratology, National Institute of Public Health-WHO Collaborating Centre for the Community Control of Hereditary Diseases, Budapest, Hungary. czeizel@oki.jaboki.hu

International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics
|June 12, 1999
PubMed
Summary

Tetanus vaccination during pregnancy does not pose a teratogenic risk to the fetus. This study found no significant difference in congenital abnormalities between vaccinated and unvaccinated pregnant women, confirming vaccine safety.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

IRF6 mutation screening in non-syndromic orofacial clefting: analysis of 1521 families.

Clinical genetics·2015
Same author

Association of certain chronic maternal diseases with the risk of specific congenital heart defects: a population-based study.

European journal of obstetrics, gynecology, and reproductive biology·2014
Same author

Phenolphthalein treatment in pregnant women and congenital abnormalities in their offspring: A population-based case-control study.

Drug discoveries & therapeutics·2012
Same author

Association of AXIN2 with non-syndromic oral clefts in multiple populations.

Journal of dental research·2012
Same author

Experience of the Hungarian Preconception Service between 1984 and 2010.

European journal of obstetrics, gynecology, and reproductive biology·2012
Same author

Possible association of folic acid supplementation during pregnancy with reduction of preterm birth: a population-based study.

European journal of obstetrics, gynecology, and reproductive biology·2009

Area of Science:

  • Reproductive Toxicology
  • Vaccinology
  • Perinatal Medicine

Background:

  • Assessing the safety of maternal vaccinations is crucial for public health.
  • Concerns about potential teratogenic effects of vaccines during pregnancy necessitate rigorous scientific evaluation.
  • Tetanus toxoid vaccination is often recommended during pregnancy to protect both mother and infant.

Purpose of the Study:

  • To investigate the potential teratogenic effects of tetanus vaccination administered during pregnancy.
  • To evaluate the safety profile of tetanus toxoid in pregnant women and its association with congenital abnormalities.

Main Methods:

  • A large population-based dataset from the Hungarian Case-Control Surveillance of Congenital Abnormalities (1980-1994) was utilized.
  • Pair analysis was conducted comparing cases with congenital abnormalities to matched healthy controls.

Related Experiment Videos

  • Data included 35,727 control pregnancies and 21,563 pregnancies with offspring abnormalities.
  • Main Results:

    • The prevalence of tetanus vaccination was 0.09% in the control group and 0.12% in the group with congenital abnormalities.
    • This difference was not statistically significant (P = 0.39), indicating no increased risk.
    • Case-control analysis confirmed the safety of tetanus vaccination, especially during the critical second and third months of gestation.

    Conclusions:

    • Tetanus vaccination during pregnancy does not appear to be teratogenic.
    • There is no contraindication for using tetanus toxoid when necessary during pregnancy.
    • The findings support the continued recommendation of tetanus vaccination for pregnant individuals.